MSI statement on the planned destruction of USAID contraceptive supplies

Policy and advocacy   |   15 July 2025   |   2 min read

Share






Copied


Responding to the US State Department’s plan to destroy USAID contraceptive supplies, Beth Schlachter, MSI’s Senior Director for US External Relations, said:

“The cruel dismantling of USAID has left women around the world struggling to access contraception. At MSI, nine out of 19 countries we surveyed reported they were already facing stockouts of at least one contraceptive method. Empty shelves in clinics and pharmacies mean women won’t be able to delay or avoid pregnancy, leaving lives and futures on the line. 

“Now, the US State Department is planning to destroy $9.7m of contraceptive supplies, which have already been paid for by the US taxpayer and are destined for women living in some of the most vulnerable communities. MSI and partners have offered to pay for the shipment and distribution of the supplies, so they can reach the people who desperately need them, but our offer was rejected.

“USAID was accused, without evidence, of wanton waste and inefficiencies, yet now the US State Department seems hellbent on destroying life-saving medical supplies, incurring additional costs for the US taxpayer in the process. Make no mistake, these actions are intentional and will cost lives.”


Notes to Editor

For interviews and further information please contact: 

Email: [email protected]  

Tel: +44 (0)7769 166 516  


Share






Copied

Related posts

News


21 May 2026   |   2 min read

Statement on UK government’s new international effort to drive progress for women and girls

MSI statement on the UK government’s new International Strategic Framework on Women and Girls, and a new

News


20 May 2026   |   1 min read

Statement on study showing that U.S. abortion bans restrict miscarriage care

MSI statement on a new study finding that abortion bans in the US are restricting miscarriage care.

News


15 May 2026   |   4 min read

MSI statement on U.S. legal actions to restrict access to mifepristone

A recent U.S. federal court ruling restricting access to mifepristone is not grounded in medical evidence and fuels